Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Isidoro González-Alvaro

Independent Candidate Serum Protein Biomarkers of Response to Adalimumab and to Infliximab in Rheumatoid Arthritis: An Exploratory Study

PLoS ONE

Multidisciplinary

2016

English

Structure-Function Relationship and Role of Tumor Necrosis Factor-Α-Converting Enzyme in the Down-Regulation of L-Selectin by Non-Steroidal Anti-Inflammatory Drugs

Journal of Biological Chemistry

English

Related publications

The Combined Use of Disease Activity and Infliximab Serum Trough Concentrations for Early Prediction of (Non-)Response to Infliximab in Rheumatoid Arthritis

British Journal of Clinical Pharmacology

Pharmacology

2013

English

Circulating Th17.1 Cells as Candidate for the Prediction of Therapeutic Response to Abatacept in Patients With Rheumatoid Arthritis: An Exploratory Research

PLoS ONE

Multidisciplinary

2019

English

Increase in Methotrexate Dose in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Infliximab

Annals of the Rheumatic Diseases

English

Infliximab in Active Early Rheumatoid Arthritis

Annals of the Rheumatic Diseases

English

Infliximab as Alternative Therapy in Renal AA Amyloidosis Secondary to Rheumatoid Arthritis

Austin Journal of Nephrology and Hypertension

2017

English

To Study the Serum Vitamin –D and Oxidative Stress Status in Rheumatoid Arthritis

Journal of Current Medical Research and Opinion

2017

English

Adalimumab in the Treatment of Early Rheumatoid Arthritis

Nauchno-Prakticheskaya Revmatologiya

English

Serum ADA and C-Reactive Protein in Rheumatoid Arthritis

International Journal of Human Genetics

Genetics

2006

English

Cost-Effectiveness of Abatacept Compared to Adalimumab in Italy Based on a Head-To-Head Outcomes Study in Rheumatoid Arthritis

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Isidoro González-Alvaro

Independent Candidate Serum Protein Biomarkers of Response to Adalimumab and to Infliximab in Rheumatoid Arthritis: An Exploratory Study

Structure-Function Relationship and Role of Tumor Necrosis Factor-Α-Converting Enzyme in the Down-Regulation of L-Selectin by Non-Steroidal Anti-Inflammatory Drugs

Related publications

The Combined Use of Disease Activity and Infliximab Serum Trough Concentrations for Early Prediction of (Non-)Response to Infliximab in Rheumatoid Arthritis

Circulating Th17.1 Cells as Candidate for the Prediction of Therapeutic Response to Abatacept in Patients With Rheumatoid Arthritis: An Exploratory Research

Increase in Methotrexate Dose in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Infliximab

Infliximab in Active Early Rheumatoid Arthritis

Infliximab as Alternative Therapy in Renal AA Amyloidosis Secondary to Rheumatoid Arthritis

To Study the Serum Vitamin –D and Oxidative Stress Status in Rheumatoid Arthritis

Adalimumab in the Treatment of Early Rheumatoid Arthritis

Serum ADA and C-Reactive Protein in Rheumatoid Arthritis

Cost-Effectiveness of Abatacept Compared to Adalimumab in Italy Based on a Head-To-Head Outcomes Study in Rheumatoid Arthritis